A study led by IBEC has won the 3rd Vanguardia de la Ciencia 2025 Prize. The research, led by Samuel Sánchez Ordoñez and with Meritxell Serra-Casablanca as lead author, proposes an innovative bladder cancer therapy based on nanorobots loaded with radiopharmaceuticals. These nanorobots are capable of moving around the bladder using urine as a source of energy.
Two research groups from the Institute for Bioengineering of Catalonia (IBEC) have been selected to participate in three projects under La Marató de 3Cat’s 2024 call for proposals, which focuses on respiratory diseases. This funding will support research into diagnosis and clinical prediction, with the aim of improving respiratory health.
Decoding the Mechanics of Brain Endothelium: CAV1-Dependent Invaginations as modulators of neurovascular coupling Fidel Lolo Romero Endothelial cells of the brain vasculature are continuously exposed to mechanical forces that regulate … Read more
The ‘Science in the Territory: Voices and Experiences in Rural Schools’ conference, held at the Terra Museum in L’Espluga de Francolí, brought science to rural areas. The event provided a platform for sharing inspiring experiences and scientific projects developed in rural schools and communities in Catalonia and other regions of Spain. The aim was to promote interconnection and foster new collaborations between individuals and organisations in the scientific, educational, and social spheres.
A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and transplanted back into the same animal in a viable manner. The experiment, led by the Institute for Bioengineering of Catalonia (IBEC), is in the preclinical phase. It confirms the safety and viability of the procedure, paving the way for future trials involving humans. In the long term, this approach could help to extend the useful life of organs intended for transplantation and provide an alternative therapy for patients with chronic kidney disease.
Part of the IBEC Thematic Network “Quasi-living systems: Merge and Emerge” (NET-QUASI), this third workshop explores how life-like function can be designed into synthetic and hybrid systems. By merging molecular, … Read more
On November 6th, ClarkeModet, in collaboration with IBEC and EIT Health, will host an event focused on the current landscape of the Advanced Therapies sector, exploring its main challenges and … Read more
